ECMELLA as a bridge to heart transplantation in refractory ventricular fibrillation: A case report.

Fiche du document

Type de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcvm.2023.1074544

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36860277

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2297-055X

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_6E4FADC87E6B5

Licences

info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/




Citer ce document

R. Giraud et al., « ECMELLA as a bridge to heart transplantation in refractory ventricular fibrillation: A case report. », Serveur académique Lausannois, ID : 10.3389/fcvm.2023.1074544


Métriques


Partage / Export

Résumé 0

Extracorporeal membrane oxygenation (ECMO) is an effective cardiorespiratory support technique in refractory cardiac arrest (CA). In patients under veno-arterial ECMO, the use of an Impella device, a microaxial pump inserted percutaneously, is a valuable strategy through a left ventricular unloading approach. ECMELLA, a combination of ECMO with Impella, seems to be a promising method to support end-organ perfusion while unloading the left ventricle. The present case report describes the clinical course of a patient with ischemic and dilated cardiomyopathy who presented with refractory ventricular fibrillation (VF) leading to CA in the late postmyocardial infarction (MI) period, and who was successfully treated with ECMO and IMPELLA as a bridge to heart transplantation. In the case of CA on VF refractory to conventional resuscitation maneuvers, early extracorporeal cardiopulmonary resuscitation (ECPR) associated with an Impella seems to be the best strategy. It provides organ perfusion, left ventricular unloading, and ability for neurological evaluation and VF catheter ablation before allowing heart transplantation. It is the treatment of choice in cases of end-stage ischaemic cardiomyopathy and recurrent malignant arrhythmias.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en